AdvanCell to participate in Jefferies Global Healthcare Conference in London
By API User
SYDNEY–BUSINESS WIRE– AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, will attend theJefferies Global Healthcare ConferenceinLondon from 17 to 20 November 2025. The AdvanCell team – Andrew Adamovich (CEO),Anna Karmann (CMO), Matthew Vincent (CBO), Simon Puttick (CSO) and Dayle Hogg (COO) – will discuss the company’s clinical and corporate progress, including … Continued